Salicylic Acid 2% /sodium Sulfacetamide Monohydrate 8%
FDA Label NDC 72934-8170

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sincerus Florida, Llc for the product Salicylic Acid 2% /sodium Sulfacetamide Monohydrate 8% (NDC 72934-8170). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions for use, sincerus florida, llc. adverse reactions, active, inactive, ndc 72934- 8170-7 salicylic acid usp 2% / sodium sulfacetamide monohydrate usp 8% . suspension 240gm, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.